Areeba Shahid

Areeba Shahid


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
MJMustafa Al Jnainati
Mustafa Al Jnainati
NINiharika Ikkurthy
Niharika Ikkurthy
MAMohammad Ayoub
Mohammad Ayoub
ASAreeba Shahid
Areeba Shahid
MBMirza Taha Baig
Mirza Taha Baig
JJJana Al Jnainati
Jana Al Jnainati
Background Superior rectal artery embolization (“Emborrhoid”) offers a catheter-based alternative for grade I–III internal hemorrhoids when office therapies fail or surgery is undesirable. Methods Following PRISMA 2020, PubMed and Embase were searched (Jan 2014–Jan 2024). Two reviewers independently screened records, extracted data, and applied RoB 2, ROBINS-I, or an adapted Newcastle–Ottawa Scale. Prespecified outcomes were technical success, clinical success (≥ 2-point fall in bleeding score or equivalent), adverse events, and recurrence. Substantial heterogeneity blocked meta-analysis; results were narratively synthesized. Results Twenty-two studies encompassing 810 procedures qualified. Technical success reached 93–100%. Clinical success ranged from 63 to 94%, yielding marked bleeding control and symptom relief. Reported complications were mild and self-limited (pelvic discomfort, nausea, and low-grade fever); no ischemic injury, continence disturbance, or mortality occurred. Recurrence necessitating repeat treatment affected 8–20% of patients, usually when collateral arterial supply persisted. Patient-reported satisfaction exceeded 80% in every series. Only two small, heterogeneous comparative studies versus rubber-band ligation or sclerotherapy were available, precluding a pooled analysis. Conclusions Current evidence suggests Emborrhoid is a safe, effective bridge between office procedures and surgery—particularly valuable for frail or anticoagulated patients. Yet small single-center cohorts, disparate techniques, and scarce head-to-head trials limit external validity. Multicenter randomized studies with harmonized outcomes and ≥ 24-month follow-up are required to confirm long-term efficacy, cost-effectiveness, and optimal patient selection.

28 June 2026 in Health Science Reports
Verified
Journal Article
Open access
ASAreeba Shahid
Areeba Shahid
TATemidire Adesiji
Temidire Adesiji
JCJoseph Conteh
Joseph Conteh
AZAbdullahi Zainab Zubairu
Abdullahi Zainab Zubairu
RARida Arif
Rida Arif
MOMalik Olatunde Oduoye
Malik Olatunde Oduoye
Background: Telemedicine in Africa has evolved from small‐scale pilots to an essential tool for enhancing healthcare access, efficiency, and equity. Early efforts faced challenges due to limited infrastructure, high costs, and weak policies. The COVID‐19 pandemic accelerated telemedicine adoption, exposing the need for stronger digital health strategies. Despite interest, many countries still struggle with regulation, coordination, and scaling sustainable implementations. This review examines the development and policy adoption of telemedicine across Africa before and after the pandemic, identifying key innovations, ongoing challenges, and lessons to guide future digital health planning. Methods: A narrative review was conducted, with study selection guided by PRISMA transparency standards. A structured search was conducted across PubMed, Google Scholar, Web of Science, Cochrane Library, Scopus, and policy databases from the WHO, the African Union, and UNECA. The search included publications from 2000 to 2025, focusing on English‐language studies addressing telemedicine policies or implementation in African countries. Results: The COVID‐19 pandemic accelerated adoption, driving rapid innovation and policy shifts. In Nigeria, platforms such as MobiHealth , Tremendoc , and Dokilink expanded access via phone and WhatsApp, maintaining care during lockdowns. In South Africa, regulatory reforms enabled consultations without prior doctor‐patient relationships, allowing 97% of patients to be managed virtually and reducing hospital burden. Nurse‐led teleconsultations improved access, while a remote diabetes program reduced mortality by 20% among high‐risk patients. Telepsychiatry expanded mental health services, and SMS‐based interventions remained the most widely used due to affordability and accessibility. Despite progress, policy responses were uneven. South Africa's rapid reforms contrasted with Nigeria's fragmented frameworks, which lacked enforceable telemedicine provisions. Persistent challenges include weak data governance, limited interoperability, inadequate funding, and “pilotitis,” where projects fail to scale. Conclusion: Telemedicine adoption in Africa has grown markedly since COVID‐19 but remains constrained by infrastructural and regulatory weaknesses, and variable acceptance. Strengthening legal frameworks, improving infrastructure, and increasing awareness among providers and communities are vital to sustain progress, integrate telehealth into routine care, foster innovation, and enhance equitable healthcare across the continent.

20 November 2024 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
FHFathimathul Henna
Fathimathul Henna
SCShamikha Cheema
Shamikha Cheema
ANAyeza Nawaz
Ayeza Nawaz
ASAreeba Shahid
Areeba Shahid
SKSaad Khan
Saad Khan